Affymetrix Launches Program to Advance Cancer Research
Partnership With Leading Scientists Aims to Accelerate Breakthroughs in More Than 10 Types of Cancers
Affymetrix Inc. announced the launch of the collaborations in Cancer Research Program, an alliance between Affymetrix and up to 30 leading European cancer researchers. As part of the program, Affymetrix will partially fund selected research projects that demonstrate clinical utility, enabling participants to develop new approaches to elucidate cancer mechanisms and to accelerate discoveries in more than 10 different forms of cancer.
The studies selected for the Collaborations in Cancer Research Program incorporate a number of different microarray-based applications, including copy number analysis, chromatin immunoprecipitation (ChIP), gene expression and splicing pattern analysis. In addition to helping participants obtain tools and training, Affymetrix will also provide forums where investigators can exchange knowledge and share best practices.
Participants in the Collaborations in Cancer Research Program were selected on the basis of past contributions to their respective fields, and the potential to make significant advancements in their current research.
Later this year, Affymetrix will expand the Collaborations in Cancer Research Program to selected groups in North America and Japan.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Phenomenex Launches Chiral Screening Service
Significant breakthrough in the chemistry of fluorinated compounds - Overcoming the “Fluoro Wall”: Researchers observe tunneling effect of heavy atoms for the first time
X-rays reveal how glasses lose their stability - PETRA III experiment shows how atoms in glass behave as weaknesses appear
Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer
PET points to tau protein as leading culprit in Alzheimer's
Syrris Establish Japanese Subsidiary Office - Syrris Expand Global Sales Network to Match Growing Demand in the Far East
Sartorius reviews fiscal 2008 - Different outlook for the two Group divisions
SGS Australia opens new Sydney Laboratory for Environmental Testing
Thermo Fisher Scientific Announces Partnership with Megaware to Deliver New Bioequivalence Solution
Neandertal genome project reaches its goal - High-quality Neandertal genome provides novel insights into human origins